Clinical Trial Update: Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating apixaban versus warfarin for reducing cognitive decline, silent cerebral infarcts, and cerebral microbleeds in atrial fibrillation; tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Apixaban (apixaban)
• Warfarin (warfarin)

Snippet

Sponsor: Mayo Clinic | Conditions: Atrial Fibrillation | Phase 3 | Status: TERMINATED | Results posted: 2021-03-16